PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates | Zendy

Katie Solomon | Zendy; Séamus Fanning | Zendy; Sinead McDermott | Zendy; Seán Murray | Zendy; Louise Scott | Zendy; Alan J. Martin | Zendy; Máiréad Skally | Zendy; Karen Burns | Zendy; Ed J. Kuijper | Zendy; Fidelma Fitzpatrick | Zendy; Lynda Fenelon | Zendy; Lorraine Kyne | Zendy

Open Access

PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates

Author(s) -

Katie Solomon,

Séamus Fanning,

Sinead McDermott,

Seán Murray,

Louise Scott,

Alan J. Martin,

Máiréad Skally,

Karen Burns,

Ed J. Kuijper,

Fidelma Fitzpatrick,

Lynda Fenelon,

Lorraine Kyne

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr275

Subject(s) - microbiology and biotechnology , clindamycin , biology , moxifloxacin , antimicrobial , antibiotic resistance , clostridium difficile , erythromycin , levofloxacin , ribotyping , vancomycin , genotype , antibiotics , genetics , bacteria , staphylococcus aureus , gene

Antimicrobial use is recognized as a risk factor for Clostridium difficile infection (CDI) and outbreaks. We studied the relationship between PCR ribotype, antimicrobial susceptibility and the genetic basis of resistance in response to exposure to antimicrobial agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research